Tel Aviv-based AI-enabled computational protein engineering platform Scala Biodesign announced its launch today with $5.5 million in seed funding.
The round was led by TLV Partners, an Israeli venture capital firm that invests in early-stage startups.
WHAT IT DOES
Scala's computational method utilizes AI, physics-based modeling and biological data analysis to engineer and improve proteins for...